Clinical features of Leber's hereditary optic neuropathy with the 11778 mitochondrial DNA mutation in Taiwanese patients

Chang Gung Medical Journal

Volumn 26, Issue 1, 2003, Pages 41-47

  Hung, Hsiang Ling ^a   Kao, Ling Yuh ^a   Huang, Chin Chang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

11778 Mutation; Age of onset; Ethnic Taiwanese patients; Leber's hereditary optic neuropathy; Visual recovery

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; EVOKED VISUAL RESPONSE; FEMALE; GENE MUTATION; HEREDITARY OPTIC ATROPHY; HUMAN; MALE; ONSET AGE; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; TAIWAN; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; CHILD; DNA, MITOCHONDRIAL; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; MUTATION; OPTIC ATROPHY, HEREDITARY, LEBER; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 0037232965     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Howell N. Primary LHON mutations: trying to separate "fruyt" from "chaff". Clin Neurosci 1994;2:130-7.
2. Huoponen K, Lamminen T, Juvonen V, Majander A. The spectrum of mitochondrial DNA mutations in families with Leber's hereditary optic neuroretinopathy. Hum Genet 1993;92:379-81.
3. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Costa JD. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995;118:319-37.
4. Lott MT, Voljavec AS, Wallace DC. Variable genotype of Leber's hereditary optic neuropathy patients. Am J Ophthalmol 1990;109:625-8.
5. Nikoskelainen E, Huoponen K, Juvonen V, Lamminen T, Nummelin K. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 1996;103:504-14.
6. Yen MY, Wang AG, Chang WL, Hsu WM, Liu JH, Wei YH. Leber's hereditary optic neuropathy? the spectrum of mitochondrial DNA mutations in Chinese patients. Jpn J Ophthalmol 2002;46:45-51.
7. Hotta Y, Fujiki K, Hayakawa M, Nakajima A, Kanai A, Mashima Y. Clinical features of Japanese Leber's hereditary optic neuropathy with 11778 mutation of mitochondrial DNA. Jpn J Ophthalmol 1995;39:96-108.
8. Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 1991;111:750-62.
9. Nikoskelainen E, Wanne O, Dahl M. Pre-excitation syndrome and Leber's hereditary optic neuroretinopathy. Lancet 1985;1:969.
10. Nishimura M, Obayashi H, Ohta M, Uchiyama T, Hao Q, Saida T. No association of the 11778 mitochondrial DNA mutation and multiple sclerosis in Japan. Neurology 1995;45:1333-4
11. Kuo HC, Huang CC, Chu CC, Kao LY, Lee HC, Wei YH. Coenzyme Q10 treatment in Leber's hereditary optic neuropathy. Neuro-Ophthalmol 2001;25:123-8.
12. Nikoskelainen E, Hoyt WF, Nummelin K. Ophthalmoscopic findings in Leber's hereditary optic neuropathy. II. The fundus findings in the affected family members. Arch Ophthalmol 1983;101:1059-68.
13. Nikoskelainen E, Hoyt WF, Nummelin K. Ophthalmoscopic findings in Leber's hereditary optic neuropathy. I. Fundus findings in asymptomatic family members. Arch Ophthalmol 1982;100:1597-1602.
14. Tsao K, Aitken PA, Johns DR. Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy. Br J Ophthalmol 1999;83:577-81.
15. Johns DR, Heher KL, Miller NR, Smith KH. Leber's hereditary optic neuropathy: clinical manifestations of the 14484 mutation. Arch Ophthalmol 1993;111:495-8.